Lou Lange

Dr. Lange has 22 years experience in academic medicine at Harvard and Washington University, where he served as Chief of Cardiology and Professor of Medicine at Jewish Hospital from 1985-1992 and was one of the first academicians in molecular cardiology. He founded CV Therapeutics based on this broad field and as Chairman, CEO and Chief Scientific Officer. Dr. Lange is a member of the Board of Trustees at the University of Rochester, and a member of BIO Board of Directors. Dr. Lange has been on numerous other public and private Boards in both the non-profit and for-profit arena. Dr. Lange has a Bachelor’s degree from the University of Rochester, an M.D. from Harvard University and a Ph.D. in Biological Chemistry, also from Harvard University.